Replies to post #3613 on Adamis Pharmaceuticals Corp (ADMP)

[Headsupmonk]

I think they can extend it again. It’s probably either due to the court case or a BO in the works. This company has multi billions in drugs currently approved and future. There’s too much money not to hold your cards. Unless you are a lottery player I would think this could be a great cheap hold. Not a financial adviser

[JJAAMMAANN]

I had asked again about posting updated financials.
Response:

Reporting up to date financials is a top priority for the company

I expect that the company will post updated financials soon, or at least post some correspondence regarding why they can not post financials. If the latter is the case, I would expect a summation of what their plan is with the SEC to stay in compliance...or another extension until USC Litigation is completed. Either way, i do not see them getting delisted.

Nov 3, 2021, 3:34 PM (21 hours ago)
to Robert

Robert,
Just looking for a follow up.
I had asked about the closing of the USC deals, and if we could expect a PR announcing any updates in the litigation regarding the compounding business.

Now, everything is pointing towards a possible delisting due to lack of financials.
Is Adamis in fact working towards meeting the SEC's deadlines?
Do you expect financials to be released before end of year?

Thanks in advance,
James


Robert Uhl (Westwicke)
Nov 3, 2021, 4:06 PM (21 hours ago)
to me

Hi James,

The sale of USC was announced in the following SEC filing:

90434175-70e8-46e9-af1c-00f2481259e2 (adamispharmaceuticals.com)



There is nothing I can tell you about future news releases or announcements. The company has not communicated information on this topic.

Reporting up to date financials is a top priority for the company but no information about the timing is available.

Best regards,

Robert